Inebilizumab
Product Specifications
CAS Number
1299440-37-1
Target
Immunology/Inflammation related, ADC Antibody
Related Pathways
Immunology/Inflammation, Antibody-drug Conjugate/ADC Related
Purity
0.993
Bioactivity
Inebilizumab is a humanized anti-CD19 monoclonal antibody with enhanced antibody-dependent cell-mediated cytotoxicity against B cells. Inebilizumab can be used to treat a range of autoimmune diseases associated with CD19 B cells, such as multiple sclerosis and optic neuromyelitis.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog